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Summary
The intrinsic refractoriness of naive T cells for cyto-
kine production is counteracted by cells of the innate
immune system. Upon sensing danger via Toll-like
receptors, these cells upregulate T cell costimulatory
molecules and secrete cytokines that enhance T cell
activation. We show that cytokine-mediated priming
of naive T cells requires the NF-B family member
c-Rel. In resting naive cells c-Rel is associated pri-
marily with IB, an inhibitory molecule that is not
effectively degraded by TCR signals. Exposure of T
cells to proinflammatory cytokines, TNF- and IL-1,
shifts c-Rel to IB-associated complexes that are
readily targeted by the TCR. As a consequence, IL-2
and IFN- mRNA are produced more quickly, and at
higher levels, in cytokine-primed T cells. This mecha-
nism does not operate in effector T cells where cyto-
kine gene expression is c-Rel-independent. We pro-
pose that c-Rel plays a crucial role as a target of
innate signals in T cells.
Introduction
The NF-κB family of transcription factors consists of
homodimers and heterodimers of Rel-homology do-
main (RHD)-containing proteins (Bonizzi and Karin,
2004; Hayden and Ghosh, 2004). Two small subunits,
p50 and p52, are generated from larger precursor pro-
teins by proteolytic processing. These subunits contain
few additional residues beyond the approximately 300
amino acid RHD, and their homodimers are constitutively
nuclear. The three larger subunits, p65/RelA, c-Rel, and
RelB, contain transcription regulatory domains in addi-
tion to the RHD. Subcellular distribution, as well as DNA
binding, of complexes that contain these Rel subunits
is regulated by interaction with inhibitory IκB proteins.
In most unactivated cells, Rel/IκB complexes are de-
tected primarily in the cytoplasm, suggesting a model
in which IκB proteins sequester Rel proteins in the cy-
toplasm. However, accumulating evidence indicates
that Rel proteins complexed to IκBα shuttle continu-
ously between the nucleus and cytoplasm of unstimu-*Correspondence: rs465z@nih.govlated cells. Thus, the predominantly cytosolic distribu-
tion of these complexes simply reflects a “snapshot” of
a dynamic state. Nuclear import of Rel/IκB complexes
is probably mediated by nuclear-localization sequences
in the Rel proteins, whereas retrieval from the nucleus
is mediated by nuclear-export sequences in IκBα and
p65/RelA (Huang et al., 2000; Tam et al., 2000; Tam et
al., 2001) . Other IκBs do not contain efficient nuclear-
export sequences (Lee and Hannink, 2002; Malek et al.,
2001; Tam and Sen, 2001) and probably regulate Rel
subcellular distribution by the sequestration mech-
anism.
Studies of lymphocytes that lack one or more Rel
subunits show that these proteins play important and
nonredundant roles in immune function (Li and Verma,
2002). Even the closely related p65/RelA and c-Rel pro-
teins serve different functions in B and T lymphocytes.
For example, c-Rel-deficient B cells die rapidly in re-
sponse to antigen receptor crosslinking without enter-
ing the cell cycle (Grumont et al., 1999; Grumont et al.,
1998; Hsia et al., 2002; Owyang et al., 2001; Yamazaki
and Kurosaki, 2003). This is attributed to diminished
transcriptional induction of Bcl-2 family anti-apoptotic
genes Bfl.A1 and BclxL. In contrast, c-Rel-deficient T
cells do not die upon TCR crosslinking, although there
is a block in proliferation that can be rescued by exoge-
nous interleukin-2 (IL-2) (Kontgen et al., 1995; Liou et
al., 1999). The major defect in c-Rel-deficient T cells is
diminished cytokine production, although the extent of
the defect varies considerably in the published litera-
ture, in part depending on the stimulus used (Hilliard et
al., 2002; Kontgen et al., 1995; Liou et al., 1999; Rao et
al., 2003). A lack of p65/RelA induction in response to
TCR stimulation leads to rapid cell death, reminiscent
of the phenotype of c-Rel-deficient B cells (Wan and
DeGregori, 2003). However, different mechanisms may
operate in the two cell types because T cell death in
the absence of NF-κB has been attributed to activation
of the p53 homolog, p73.
Unactivated B and T lymphocytes differ in the com-
position of NF-κB/IκB complexes in one major way.
Whereas p65/RelA protein is complexed to IκBα and
IκBβ in both cell types, c-Rel is complexed primarily to
IκBβ in T cells (Tam et al., 2001). Thus, IκBα-degrading
signals, such as those initiated at the T cell receptor or
its pharmacologic equivalent, induce only p65/RelA by
the classical post-transcriptional pathway of NF-κB
activation (Venkataraman et al., 1996). Nuclear c-Rel
expression requires new gene transcription and trans-
lation by a pathway that is suppressed by FK506 or
cyclosporin A (Venkataraman et al., 1995, 1996; Grumont
et al., 2004). This mechanism results in slower c-Rel
induction and, as a consequence, slower c-Rel-depen-
dent gene transcription compared to p65/RelA-depen-
dent genes that are rapidly activated. Signals initiated
at the B cell antigen receptor target both IκBα and IκBβ,
which leads to rapid post-translational induction of
p65/Rel A as well as c-Rel (Venkataraman et al., 1996).
Because such features of NF-κB regulation may ex-
plain phenotypic aspects of the responses of activated
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c-Rel/IκB association in T cells. We found that the pro-
portion of c-Rel associated with IκBα increased sub-
stantially in cells pre-activated with TNF-α or interleu-
kin-1 (IL-1). This was due to the shuttling property of
newly synthesized IκBα, which migrated into the nu-
cleus and exported nuclear c-Rel out to the cytoplasm.
Consequently, T cells that had previously seen cyto-
kines responded to IκBα-degrading signals initiated at
the TCR by rapidly activating c-Rel nuclear transloca-
tion, and c-Rel-dependent cytokine gene expression
was significantly increased. These observations sug-
gested that inflammatory-cytokine-induced alteration
of c-Rel/IκB complexes may prime naive T cells to TCR
signals. Consistent with this hypothesis, we found that
T cells from CFA-primed wild-type, but not c-Rel-defi-
cient, mice responded robustly to TCR stimulation by
inducing high levels of interleukin-2 (IL-2) and inter-
feron-γ (IFN-γ) gene transcription. Interestingly, c-Rel-
mediated priming did not occur in effector T cells, in
which IL-2 and IFN-γ gene expression was c-Rel inde-
pendent. We propose that the shift of c-Rel to IκBα in
T cells induced by inflammatory cytokines constitutes
one form of communication between cells of the innate
and adaptive immune systems during the generation of
a primary immune response.
Results
c-Rel/IB Complex Formation in Response
to Inflammatory Cytokines
Unactivated D5h3 T hybridoma cells contain predomi-
nantly c-Rel/IκBβ complexes, whereas p65/RelA is as-
sociated with both IκBα and IκBβ. Acute treatment with
TNF-α induced IκB degradation (Figure 1A, left panel)
and nuclear translocation of c-Rel and p65/RelA (Figure
1A, right panel). TNF-α withdrawal was accompanied
by resynthesis of both IκBs and loss of nuclear NF-κB
to regenerate the cytoplasmic pool of IκB-associated
Rel proteins (Figure 1A). However, cells that were pre-
treated with TNF-α differed from unactivated cells in
that they contained significant levels of c-Rel/IκBα
complexes as assayed by immunoprecipitation fol-
lowed by immunoblotting (Figure 1A, lower panel, lanes
6–9). The proportion of p65 or c-Rel bound to IκBβ ver-
sus IκBα is indicated below the gel and shows that 6
hr after TNF-α withdrawal approximately 30% of cyto-
solic c-Rel was associated with IκBα compared to less
than 5% in untreated cells. Because the total amount of
c-Rel did not change over the experimental time course
(Figure 1A), the absolute amount of c-Rel/IκBα com-
plexes increased after cytokine treatment. c-Rel shift to
IκBα was most likely due to newly synthesized IκBα,
which migrated into the nucleus, bound Rel proteins,
and exported them to the cytoplasm. Consistent with
this idea, inclusion of leptomycin B to block nuclear
export prevented c-Rel localization to the cytoplasm
(data not shown). The slower resynthesis of IκBβ (Fig-
ure 1A, top left panel) accentuated the role of IκBα dur-
ing this phase of NF-κB downregulation from the nu-
cleus.
To determine if continued TNF-α signaling also re-
sulted in a shift of c-Rel to IκBα, we treated D5h3 T
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pybridoma cells with different amounts of TNF-α for 6
r and then analyzed IκB/Rel complexes by coimmuno-
recipitation. Although c-Rel was primarily associated
ith IκBβ in unactivated cells (Figure 1B, lanes 2-4), sig-
ificant c-Rel/ IκBα complexes were detected in cells
reated with low levels of TNF-α (Figure 1B; compare
anes 5, 7 and 9 to lane 3). A similar shift to IκBα associ-
tion was evident in primary CD4+ T cells in response
o TNF-α (Figure 1C; compare the proportion c-Rel on
κBα and IκBβ in lanes 3 and 4 to that in lanes 5 and
). Another NF-κB-inducing cytokine, interleukin 1-β
IL-1β), as well the combination of TNF-α plus IL-1, also
ncreased the number of c-Rel/IκBα complexes even
ore effectively than TNF-α alone (Figure 1C; compare
anes 7–10 to lanes 3 and 4). We verified the efficiency
nd specificity of IκBβ immunoprecipitation by assay-
ng the immunoprecipitation supernatants for the ap-
ropriate proteins (Figure S1B in the Supplemental
ata available with this article online). Because this
hift occurred without significant alteration in the levels
f either Rel or IκB proteins (Figure S1A), we conclude
hat proinflammatory cytokines such as TNF-α and
L-1β increase the overall levels of c-Rel/IκBα com-
lexes in T cells. Consistent with the increase in c-Rel/
κBα complexes in cytokine-treated cells, we observed
ore efficient c-Rel induction in response to anti-CD3
rosslinking, which is primarily an IκBα degrading sig-
al (Figure S1C).
ytokine Gene Expression in TNF/IL-1
retreated Cells
nflammatory cytokines, such as TNF-α, IL-1, and IL-6
ave been previously shown to enhance T cell prolifera-
ion in vivo and in vitro (Curtsinger et al., 1999; Khoruts
t al., 2004; Kurt-Jones et al., 1987; Pape et al., 1997;
ojo et al., 1989; Teague et al., 2000). These cytokines
ave also been recently shown to overcome age-related
eficiency of naive CD4+ T in the production of interleu-
in-2 (IL-2) (Haynes et al., 2003; Haynes et al., 2004).
ecause c-Rel has been previously implicated in IL-2
ene expression, our observation that TNF-α and IL-1
hifted c-Rel to rapidly activatable IκBα-associated
omplexes provided a possible mechanism for the co-
timulatory activity of these cytokines. To test this, we
xamined the effect of TNF-α and IL-1 on cytokine gene
xpression in splenic CD4+ T cells from normal and
-Rel-deficient mice.
Purified CD4+ T cells were treated with the cytokines
or 6 hr and subsequently stimulated with low levels of
late-bound anti-CD3 antibody. IL-2 and IFN-γ expres-
ion was scored by quantitative RT-PCR with total RNA
solated after various times of CD3 activation. We ob-
erved 3- to 5-fold higher IL-2 and IFN-γ mRNA expres-
ion in normal cells that had been treated with IL-1
lone or with IL-1 plus TNF-α (Figure 2A). TNF-α alone
id not affect gene expression significantly in these as-
ays despite its being able to generate c-Rel/IκBα com-
lexes. We surmise this may be because of more pleio-
ropic effects of TNF-α on T cells (Clark et al., 2004;
somaki et al., 2001), including effects on TCR signaling
Church et al., 2005). At this level of stimulation, IL-2
nd IFN-γ induction in c-Rel−/− CD4+ T cells was com-
arable to that seen in unprimed normal CD4+ T cells
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447Figure 1. Pro-Inflammatory Cytokines Induce
Formation of c-Rel/IκBα Complexes in T
Lymphocytes
(A) c-Rel/IκBα complex formation with acute
TNF-α stimulation. D5h3 T hybridoma cells
were treated with TNF-α (10 ng/ml) for 15
min ([+T] 15#) and then incubated for various
times in the absence of the cytokine (−T).
Whole-cell extracts (WCE) and nuclear ex-
tracts (NE) prepared from these cells were
fractionated by SDS-PAGE and immunoblot-
ted with antibodies against p65, c-Rel, and
IκBα and IκBβ molecules as indicated. Pro-
tein kinase D (PKD) and the transcription fac-
tor SP1 were used to confirm comparable
protein loadings between extracts. Results
shown are representative of more than six
independent experiments. WCE were used
for coimmunoprecipiation studies (Co-IP)
(bottom panel). The origin of extracts is
noted on the top line above the figure, and
the immunoprecipitating antibody (IP Ab) is
noted on the second line; IgG represents
non-specific rabbit IgG, and α and β repre-
sent anti-IκBα and anti-IκBβ antibodies, re-
spectively. The immunoprecipitates were frac-
tionated by SDS-PAGE and transferred to
nitrocellulose membranes, which were probed
with anti-p65/RelA, anti-c-Rel, and anti-IκBα
antibodies as indicated to the left of the
panel. The proportion of p65/RelA, or c-Rel,
bound to IκBβ compared to IκBα was quanti-
fied as described in the Experimental Pro-
cedures and is indicated below the gels. The
data is representative of three independent
experiments.
(B) c-Rel/IκBα complex formation with con-
tinuous TNF-α stimulation. T hybridoma cells
were treated with various levels of TNF-α
(shown on the top line) for 6 hr followed by
preparation of whole-cell extracts. c-Rel or
p65/RelA associated with IκBα or IκBβ was
determined by coimmunoprecipiation as de-
scribed in the legend to (A). Data shown are
representative of three independent experi-
ments.
(C) c-Rel/IκBα complex formation in primary
CD4+ T cells. CD4+ T cells, purified by posi-
tive selection with anti-CD4-coated mag-
netic beads, were treated with TNF-α (5 ng/ml), interleukin 1β (IL-1β, 5 ng/ml), or both together for 6 hr, followed by preparation of whole-cell
extracts. c-Rel or p65/RelA association with IκBα was determined by coimmnoprecipitation experiments as described in the legend to (A).
The top arrow indicates the position of c-Rel; the lower band in anti-IκBβ immunoprecipitates has not been characterized. Data shown are
representative of three independent experiments.(additional bars to the right of the time course in Figure
2B), indicating that c-Rel is not essential for inducible
transcription of these genes. However, TNF-α- and IL-
1-treated c-Rel−/− CD4+T cells did not express higher
levels of IL-2 or IFN-γ mRNA, indicating that c-Rel was
essential for the “super-induction” seen in normal cells
pretreated with TNF-α and IL-1.
These observations are consistent with a mechanism
whereby increased levels of c-Rel/IκBα complexes in
TNF-α- and IL-1-treated cells enhanced the subse-
quent responsiveness of these cells to stimulation via
the TCR. We hypothesized that these complexes are
generated by export of nuclear c-Rel by newly synthe-
sized IκBα. To further corroborate a role for nuclear ex-
port and cytoplasmic reactivation, we used IκBα mu-
tants that either lacked the N terminus (and thus couldnot be targeted by IκB kinases) or inactivated an N-ter-
minal nuclear-export sequence (NES) that severely re-
duced its export-chaperone ability (Huang et al., 2000;
Huang and Miyamoto, 2001; Tam et al., 2001). For
reasons outlined below (see Figure 6 and accompany-
ing discussion), these experiments were carried out in
D5h3T hybridoma cells. We expressed IκBα mutants by
using retroviral gene transfer and compared cytokine
gene expression in sorted GFP+ (infected) and GFP−
(uninfected) cells that had been pretreated with TNF-α,
or not (the fact that D5h3 hybridoma cells were refrac-
tory to IL-1 precluded its use in these studies).
TNF-α pretreatment resulted in approximately 2.5-
fold-enhanced IL-2 mRNA expression in response to
anti-CD3 in uninfected cells (Figure 3A, top panel). This
priming effect was abolished in cells that expressed
Immunity
448Figure 2. TNF-α and IL-1β Prime Normal, but Not c-Rel-Deficient, CD4+ T Cells for Increased Cytokine mRNA Production
Purified splenic CD4+ T cells from normal (A) or c-Rel-deficient (B) mice were treated continuously for 6 hr with TNF-α, IL-1β, or TNF-α and
IL-1β in-vitro, and activation with plate bound anti-CD3 antibodies (0.5 g/ml) followed for the times indicated (x axis). Total RNA prepared
from the cells was examined for IL-2 (left panel) and IFN-γ (right panel) expression via quantitative RT-PCR as described in the Experimental
Procedures section. The signals were normalized to TCRβ mRNA and represented as “Fold Induction” (y axis) over the basal level detected
in cells prior to CD3 activation. RNA assays were carried out in duplicate, and error bars shown represent the standard error within the
duplicate. For ease of comparison, additional bars marked WT/untreated in (B) show the level of cytokine mRNA in normal cells not treated
with TNF-α or IL-1β as an average of three to four independent experiments. Data shown are representative of two independent experiments
with normal and c-Rel-deficient cells.both forms of mutated IκBα genes. N-IκBα-express-
ing cells produced somewhat lower levels of IL-2 after
TNF-α pretreatment (Figure 3A, middle panel), whereas
the effect was greatly diminished in NES−-IκBα-express-
ing cells (Figure 3A, bottom panel). The residual en-
hancement seen with NES−-IκBα may be due to a
weaker NES at the IκBα C terminus (Ossareh-Nazari et
al., 1997), which remains intact in our mutant. We con-
clude that IκBα-dependent nuclear export and reacti-
vation in the cytoplasm are essential to prime T cells
for enhanced IL-2 gene expression.
To further assess the role of IκBα in priming splenic
CD4+ T cells, we used siRNA to downregulate endoge-
nous IκBα. IκBα or a control siRNA was introduced into
primary CD4+ T cells by electroporation, resulting in
2-fold reduction of steady-state IκBα mRNA measured
by RT-PCR (Figure 3B, left panel). To determine the ef-
fect on IκBα protein, we treated these cells with IL-1β
for 6 hr and analyzed whole-cell extracts by immu-
noblotting. IκBα protein levels were reduced in IκBα-
siRNA-transfected cells irrespectively of IL-1 treatment
(Figure 3B, right panel). Importantly, IκBβ protein levels
were not affected by IκBα-siRNA or IL-1 treatment.
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tpon activation with anti-CD3, we detected the ex-
ected enhancement of IL-2 (Figure 3C) or IFN-γ (Figure
D) gene induction by IL-1β costimulation in cells trans-
ected with control siRNA (labeled “c”). However, IL-1-
ependent enhancement was not seen in IκBα-siRNA
ransfected cells (labeled “α”). We conclude that IκBα
s essential for effective enhancement of IL-2 and
FN-γ transcription in these cells. Taken together with
he phenotype of c-Rel−/− primary CD4+ T cells, these
bservations support the proposition that naive T cells
ay be primed for TCR-induced cytokine gene expres-
ion by increased levels of c-Rel/IκBα complexes gen-
rated in response to proinflammatory cytokines.
n Vivo Priming Requires c-Rel
ells of the innate immune system participate actively
n adaptive responses by enhancing antigen presenta-
ion, by providing costimulatory “second” signals via
pregulation of coreceptor ligands, and by producing
nflammatory cytokines (Allison, 1994; Banchereau and
teinman, 1998; Hoebe et al., 2004; Sharpe and Freeman,
002). Our in vitro results described above suggested
hat inflammatory cytokines might affect T lymphocytes
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449Figure 3. Enhanced Cytokine Gene Expression in Primed Cells Requires IkBα
(A) D5h3 hybridoma cells were infected with a retroviral vector that contained either a dominant-negative IκB (N-IκB) or a mutated N-terminal
nuclear export sequence (NES) containing IκBα (NES--IκB). Infected cells were sorted by flow cytometry to 99% purity into GFP-negative
(top) and GFP-positive (middle and bottom) populations. The purified cells were left untreated or were treated with TNF-α before being
activated with plate bound anti-CD3 (0.5 g/ml) for the indicated times (x axis). Total RNA prepared from the cells was examined for IL-2
expression via quantitative RT-PCR as described in the Experimental Procedures section. The signals were normalized to TCRβ mRNA and
represented as “Fold Induction” (y axis) over the basal level in cells not activated with anti-CD3. Anti-CD3-mediated activations were carried
out in duplicate, and the data are an average of two independent experiments. The error bars shown represent the standard error within
the duplicates.
(B) SiRNA-mediated knockdown of IκBα in primary CD4+ T cells reduces priming by IL-1β. CD4+ splenic T cells were electroporated with
control (c) or IκBα-specific (α) siRNA followed by analysis of IκBα mRNA levels via quantitative RT-PCR (left panel). The effect on IκBα protein
was examined in whole-cell extracts prepared from cells cultured in the presence or absence of IL-1β (5 ng/ml) for 6 hr. (right panel).
(C) IL-1β-treated or control cells were activated with plate-bound anti-CD3 (0.5 g/ml) for 4 hr and IL-2 or IFN-γ mRNA expression was
quantitated by RT-PCR as described. Expression levels between samples were normalized to TCRβ mRNA and expressed as “Fold Induction”
(y axis) over the basal levels in cells not activated with anti-CD3. Results shown were obtained from two independent transfection experiments
analyzed for RNA in triplicates, and the error bars represent the standard error between the two sets.by increasing the proportion of c-Rel/IκBα complexes.
To extend these observations, we determined whether
in vivo activation of innate cells enhanced T cell re-
sponses by a c-Rel-dependent pathway.
We isolated spleen and lymph-node T cells from mice
that had been injected with complete Freund’s adjuvant
(CFA) or saline (PBS) for two days, stimulated them with
plate bound anti-CD3 antibodies, and assayed cytokine
gene expression by quantitative RT-PCR as describedabove. We observed faster kinetics and higher levels of
IL-2 mRNA production in T cells from normal mice in-
jected with CFA than we did in PBS-injected controls
(Figure 4A) or incomplete-Freund’s-adjuvant-injected
controls (Figure S2). The effect of CFA injection was
substantially more pronounced on IFN-γ gene activa-
tion (Figure 4A; also Figure S3A). In contrast, there was
virtually no difference in the level of cytokine gene tran-
scription in c-Rel−/− T cells from either CFA-injected or
Immunity
450Figure 4. Adjuvant-Mediated Priming of T Cells Requires c-Rel
WT/B6 (A) or c-Rel−/− (B) mice were injected intraperitoneally with complete Freund’s adjuvant (CFA) or saline (PBS) followed by a second
injection of incomplete Freund’s (IFA) and PBS, respectively, on the next day. Three days later, spleen and lymph-node (LN) T cells were
activated with plate bound anti-CD3 (0.5 g/ml), and the levels of IL-2 (left) and IFN-γ (right) mRNA were determined as described in the
legend to Figure 2. RNA assays were carried out in duplicate, and error bars shown represent the standard error within the duplicate. For
ease of comparison, additional bars marked WT/untreated in (B) show the level of cytokine mRNA in normal cells treated with PBS; this level
is an average of 5–6 independent experiments. “Fold Induction” (y axis) represents the level of cytokine gene expression over the basal level
in cells prior to anti-CD3 treatment. A representation of absolute mRNA levels is shown in Figures S3A and S3B. Data shown are representative
of three independent experiments involving normal and c-Rel-deficient mice.
(C) WT/B6 mice were intraperitoneally injected with CFA or PBS and CD4+ T cells were rapidly purified from spleen and lymph nodes in the
cold. Whole-cell extracts prepared from these cells were used for coimmunoprecipiation studies (Co-IP) (left panel). The origin of extracts is
noted on the top line above the figure, and the immunoprecipitating antibody is noted on the second line; IgG represents non-specific rabbit
IgG, and α and β represent anti-IκBα and anti-IκBβ antibodies, respectively. Specificity and efficiency of immunoprecipitations were confirmed
by immunoblotting analysis of immunoprecipitation supernatants (Figure S3C). The immunoprecipitates were fractionated by SDS-PAGE and
transferred to nitrocellulose membranes, which were probed with anti-p65/RelA, anti-c-Rel, and anti-IκBα antibodies, as indicated. The data
are representative of at least three independent experiments.
(D) The proportion of p65/RelA or c-Rel bound to IκBβ compared to IκBα was quantified as described in the Experimental Procedures, and
the average of three independent experiments is represented graphically. Error bars represent the standard error between experiments.PBS-injected mice (Figure 4B). The easily detectable
induction of IL-2 and IFN-γ expression in c-Rel−/− T cells
from PBS-injected mice reconfirmed that c-Rel was not
essential for inducible gene transcription. However, the
p
c
i
Iriming effect of CFA was completely absent in the
-Rel-deficient T cells. In all cases we verified that CFA
njection did not significantly elevate basal IL-2 or
FN-γ gene expression in the absence of anti-CD3 treat-
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of absolute mRNA levels under these conditions). We
also stained cells intracellularly for IL-2 and IFN-γ to
ascertain whether increased mRNA reflected a greater
proportion, or a higher level, of expression in the
primed cells. For both CD4+ and CD8+ T cells, we found
that cytokine levels were higher in primed cells (data
not shown). These observations indicate that c-Rel is
important for priming naive T cells for increased IL-2
and IFN-γ production.
To determine whether CFA injection altered the pro-
portion of c-Rel/IκBα complexes, we isolated CD4+ T
cells from the spleens of injected mice and assayed
whole-cell extracts for c-Rel and p65/RelA association
with IκBα and IκBβ. We found comparable levels of
p65/RelA associated with IκBα or IκBβ in T cells from
control (PBS-injected) or CFA-injected mice (Figure 4C).
However, more c-Rel was associated with IκBα in CFA-
injected mice (Figure 4C; quantitated in Figure 4D). In
each case we verified that the IκB antibody quantita-
tively depleted the appropriate protein by analyzing su-
pernatants from the coimmune precipitation experi-
ments (Figure S3C). These results are consistent with
the hypothesis that CFA priming in vivo resulted in a
shift of c-Rel from IκBβ- to IκBα-associated complexes.
c-Rel-deficient innate immune cells produce lower
levels of certain cytokines (Boffa et al., 2003; Grigori-
adis et al., 1996), such as interleukin 12 (Mason et al.,
2002; Ouaaz et al., 2002; Sanjabi et al., 2000). Although
a requirement for c-Rel for TNF-α or IL-1β production
has not been directly demonstrated, the absence of T
cell priming by CFA in c-Rel-deficient mice may be due
to ineffective activation of innate immune cells in these
mice. To address this, as well as determine whether
TNF-α and IL-1β could prime T cells in vivo, we assayed
IL-2 and IFN-γ mRNA expression in T cells isolated from
mice treated with TNF-α plus IL-1β.
Total T cells were isolated from lymph nodes and
spleens of mice injected with these cytokines, or with
PBS as a control, and activated in vitro with anti-CD3
antibodies. We found significantly higher levels of IL-2,
as well as IFN-γ, mRNA in T cells from TNF-α-, IL-1β-
treated mice (Figure 5A). The difference in IFN-γ mRNA
between cytokine-injected and control mice was not as
large as that seen with CFA treatment. It is possible
that innate cells from CFA-injected animals produced
additional cytokines, such as IL-12, which enhanced
IFN-γ production in T cells (Curtsinger et al., 1999;
Schmidt and Mescher, 2002). Unlike the effect in normal
mice, T cells from c-Rel−/− mice injected with TNF-α
and IL-1β did not show elevated IL-2 or IFN-γ gene
transcription in comparison to control (PBS-injected)
c-Rel−/− mice (Figure 5B). We confirmed that the in-
creases seen in TNFα+IL-1β-primed mice were also re-
flected in the absolute levels of IL-2 and IFN-γ mRNA
(Figures S4A and S4B).
To directly examine the priming effect on CD4+ T
cells, we assayed IL-2 and IFN-γ expression after CD3
activation of purified CD4+ cells fom normal mice, or
DO11 TCR transgenic mice on a RAG2-deficient back-
ground, that had previously been primed with CFA or
with TNFα plus IL-1β. In both cases, we observed in-
creased IL-2 and IFN-γ mRNA in cells from treated mice
(Figures S5 and S6).CD4+ T cells from TNF-α-, IL-1β injected mice also
showed a shift of c-Rel to IκBα-associated complexes
(Figure 5C), although the magnitude of the effect was
smaller than that seen with CFA. Immunoprecipation
efficiency and specificity was confirmed by assaying
the immunoprecipitation supernatants (Figure S4C). We
conclude that pro-inflammatory cytokines prime T cells
in vivo by altering the proportion of c-Rel/IκBα com-
plexes. The altered proportion of c-Rel associated with
either IκBβ or IκBα probably indicates a change in the
amount of c-Rel/IκBα complexes because total c-Rel,
or p65, levels did not vary significantly in various cell
preparations.
Cytokine Priming Is a Feature of Naive T Cells
In published reports, the difference in IL-2 or IFN-γ
production by normal or c-Rel−/− T cells in response
to high levels of anti-CD3 or anti-CD3 plus anti-CD28
(CD3+CD28) varies considerably. With one exception,
however, c-Rel−/− T cells always produce less cytokine
than normal cells (Hilliard et al., 2002; Kontgen et al.,
1995; Liou et al., 1999; Rao et al., 2003). In contrast,
pharmacologically activated c-Rel−/− and normal T cells
make comparable levels of IL-2 or IFN-γ (Grigoriadis et
al., 1996; Kontgen et al., 1995). In our study, low-level
CD3 stimulation of splenic T cells resulted in no more
than 2- to 2.5-fold-reduced cytokine mRNA in c-Rel−/−
splenic T cells compared to normal cells. These obser-
vations suggest that IL-2, or IFN-γ, gene transcription
can be activated by c-Rel-dependent or c-Rel-indepen-
dent pathways. Indeed, differential activation of the two
pathways may be part of the explanation for the wide
variation that earlier studies noted between normal T
cells and c-Rel−/− T cells.
A hallmark of effector T cells, compared to naive T
cells, is their rapid and elevated expression of cytokine
genes in response to TCR signals. It was therefore of
interest to determine whether c-Rel was required for
elevated IL-2 and IFN-γ transcription in effector cells,
as well as to determine whether these cells could be
“primed” by TNF-α and IL-1β. To do this, we expanded
splenic CD4+ T cells from normal, or c-Rel−/−, mice by
treatment with immobilized anti-CD3 plus soluble anti-
CD28 in the presence of rIL-2 and assayed cytokine
gene expression in response to TCR signals.
As expected, IL-2 expression in CD4+ splenic T cells
was significantly enhanced by CD28 costimulation at
two concentrations of activating antibodies (Figure 6A).
Interestingly, the level of IL-2 mRNA expression in re-
sponse to anti-CD3 and anti-CD28 (0.5 g/ml) was sim-
ilar to that produced in response to 0.5 g/ml CD3 plus
TNF-α and IL-1β priming (Figure 2). Thus, cytokine co-
stimulation compared favorably with CD28 costim-
ulation, at least under conditions of limiting TCR stimu-
lation. CD28-mediated enhancement was entirely c-Rel
dependent (Figure 6A, left panel), consistent with earlier
observations that the CD28 response element is a tar-
get of c-Rel (Himes et al., 2000; Rao et al., 2003). In
contrast, although IL-2 mRNA was expressed at much
higher levels in CD3 blasts and remained CD28 costim-
ulation dependent, we found that c-Rel−/− T cells re-
sponded no differently than normal CD4+ T cells (Figure
6B). These observations indicate that the c-Rel require-
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452Figure 5. TNF-α- and IL-1β-Mediated Priming of T Cells is c-Rel Dependent
WT/B6 (A) or c-Rel−/− (B) mice were injected intraperitoneally with adjuvant cytokines, TNF-α and IL-1β, or PBS, as described in the Experi-
mental Procedures section. IL-2 and IFN-γ production was determined by quantitative real-time RT-PCR as described previously. RNA assays
were carried out in duplicate, and error bars shown represent the standard error within the duplicate. For ease of comparison, additional bars
marked WT/untreated in (B) show the level of cytokine mRNA in normal cells treated with PBS, and this level is an average of 5–6 independent
experiments. “Fold Induction” (y axis) represents the level of cytokine gene expression over basal levels in cells prior to anti-CD3 treatment.
A representation of absolute mRNA levels is shown in Figures S4A and S4B. The data are representative of at least three independent
experiments with normal and c-Rel-deficient mice. (C) CD4+ T cells were rapidly purified from spleen and lymph nodes of cytokine-primed or
control mice in the cold and immunoprecipitated as described in (C) of Figure 4. Immunoprecipitation, efficiency, and specificity were con-
firmed by analysis of supernatants (Figure S4C). Co-immunoprecipitated proteins were visualized by immunoblotting after separation by SDS-
PAGE. Data shown are representative of three independent experiments. (D) The proportion of p65/RelA or c-Rel bound to IκBβ compared to
IκBα was quantified as described in the Experimental Procedures, and the average of three independent experiments is represented graphi-
cally. As discussed in the text, because the levels of c-Rel and p65 do not change with TNFα or IL-1β treatment, the altered proportions
reflect a change in the amount of c-Rel/IκBα complexes. Error bars represent the standard error between experiments.ment for CD28 costimulation of IL-2 gene expression is
a property of naive cells only.
Although IFN-γ induction was much less dependent
on CD28 costimulation, we again noted differences be-
tween normal and c-Rel-deficient cells only in freshly iso-
lated splenic preparations (Figure 6A, right panel). As ob-
s
c
t
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s
Ferved for IL-2, CD3 blasts from normal or c-Rel−/− T
ells responded robustly to even very low concentra-
ions of anti-CD3 alone or various combinations of anti-
D3 and anti-CD28 (Figure 6B). These data are repre-
ented in terms of absolute mRNA levels in Figure S7.
inally, we treated blast cells with TNF-α and IL-1β prior
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453Figure 6. c-Rel-Dependent Priming Is a Feature of Naive CD4+ T Cells
(A) CD4+ T cells ere purified from the spleen of WT/B6 or c-Rel−/− mice and activated with various levels of immobilized anti-CD3 or with anti-
CD3 plus anti-CD28 antibodies for 4 hr. RNA prepared from these cells was assayed for IL-2 and IFN-γ gene expression by quantitative real-
time RT-PCR. “Fold Induction” (y axis) represents the level of cytokine gene expression over basal levels in cells prior to anti-CD3 treatment.
A representation of absolute mRNA levels is shown in Figure S7. The data shown are representative of three independent experiments done
in triplicate.
(B) CD4+ T cell blasts were prepared as described in the Experimental Procedures section from normal and c-Rel−/− mice. After overnight
rest in fresh medium without IL-2, the cells were activated with immobilized anti-CD3 or with anti-CD3 plus anti-CD28, as indicated, for 4 hr.
RNA prepared from these cells was assayed for IL-2 and IFN-γ expression by quantitative real-time RT-PCR. The data are representative of
three independent experiments done in duplicate, with error bars representing the standard error within duplicates.to TCR activation; however, this had no effect on IL-2
or IFN-γ expression (data not shown). This was not due
to faulty TNF-α (or IL-1) signaling because IκBα degra-
dation in response to these cytokines occurred normally
in wild-type and c-Rel-deficient cells. We conclude that
c-Rel-dependent priming of IL-2 and IFN-γ gene expres-
sion is a unique feature of naive T cells. Not only are
effector T cells no longer sensitive to this pathway, but
high-level cytokine gene expression in these cells is
c-Rel independent.Discussion
Considerable experimental evidence supports the model
in which three signals are required to optimally activate
naive T cells to proliferate. These are (1) signals initi-
ated at the T cell receptor, (2) the CD28 coreceptor, and
(3) the presence of inflammatory cytokines. Although
MHC molecules that serve as ligands for the TCR are
constitutively expressed on APC (but subject to further
modulation), upregulation of c-stimulatory molecules
Immunity
454CD80 and CD86, which are CD28 coreceptor ligands,
and pro-inflammatory cytokine gene expression require
APC activation by Toll-like receptors (Akira and Takeda,
2004; Beutler, 2004). The latter signals ensure that T cell
activation in vivo is largely restricted to situations
where innate immunity has already been triggered by
the incoming antigen. Our observations implicate c-Rel,
an NF-κB family member, as an essential component of
the communication between innate immune cells and
primary T cell responses.
The mechanism we propose is based on our earlier
observation that resting T cells contain predominantly
c-Rel/IκBβ complexes. This c-Rel is refractory to re-
lease by TCR-initiated signals, which do not target IκBβ
efficiently. Thus, the only way to induce nuclear c-Rel
protein for cytokine (IL-2 and IFN-γ) gene expression is
via new c-Rel gene transcription and translation. We
now show that pro-inflammatory cytokines generate
c-Rel/IκBα complexes by increasing IκB turnover and
export of nuclear c-Rel by newly synthesized IκBα (Fig-
ure 7). These primed T cells are much more responsive
to TCR signals, which readily target IκBα, resulting in
rapid mobilization of c-Rel to the nucleus and c-Rel-
dependent gene expression. Lack of inflammatory cy-
tokine-mediated priming in c-Rel-deficient T cells in vi-
tro, and in vivo, underscores the importance of c-Rel in
this process.
It is interesting to note that the other form of danger
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In the cytosol of naive T cells, the NF-κB family member c-Rel is complexed primarily to the inhibitor IκBβ, whereas p65/RelA is complexed
to IκBα and IκBβ (lower line, labeled Naive). Pathogen recognition by antigen-presenting cells leads, via NF-κB activation, to secretion of
pro-inflammatory cytokines such TNF-α, IL-1, and IL-6, as well as upregulation of costimulatory molecules CD80 and CD86. These cytokines
induce IκBα turnover with a consequent shift of c-Rel to IκBα-associated complexes in primed T cells (lower line, labeled “Cytokine Primed”);
c-Rel/IκBα complexes are readily targeted by TCR-initiated signals, leading to faster and higher levels of IL-2 and IFN-γ gene expression.
Costimulatory signals transmitted by CD28/CD80, 86 interactions also target c-Rel by increasing IκBβ degradation. Both mechanisms contrib-
ute to efficient c-Rel induction and, therefore, increased efficiency of IL-2 and IFN-γ gene transcription. We propose that c-Rel serves as a
danger sensor in T cells.ensing, via upregulation of costimulatory molecules,
lso targets rapid c-Rel nuclear translocation. CD28-
nitiated costimulatory signals have been extensively
tudied, but a qualitative difference between one (TCR
lone) and two signals that accounts for increased
L-2 production has been difficult to discern (Kane et
l., 2002). Indeed, recent studies conclude that the dif-
erence between CD3 alone versus CD3 plus CD28 sig-
als may be a quantitative one (Diehn et al., 2002;
eske et al., 2001). One aspect of NF-κB biology, how-
ver, appears to be qualitatively different. Specifically,
D3 plus CD28 signals target both IκBα and IκBβ in
ell lines as well as primary cells (Harhaj et al., 1996;
hou et al., 2002). In light of our observation that most
f the c-Rel in unactivated T cells is IκBβ bound, the
D28 costimulus results in c-Rel activation by the clas-
ical, post-translational mechanism of NF-κB activation.
hus, both CD28 costimulation and proinflammatory
ytokines have the same effect on c-Rel in naive T cells;
hey help activate c-Rel rapidly in response to antigen
nd thus enable faster and higher levels of IL-2 and
FN-γ gene expression.
Recent studies underscore the fact that upregula-
ion of costimulatory molecules (UCM) is not sufficient
o provide effective costimulation (Hoebe et al., 2003;
aisho et al., 2001; Pasare and Medzhitov, 2004).
pecifically, UCM and TNF-α production are both im-
aired in Trif-deficient macrophages in response to
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455LPS, whereas only TNF-α production is diminished in
Myd88-deficient macrophages. However, compared to
normal mice, both mutants have reduced T cell re-
sponses. Because UCM was unaltered in Myd88−/−
cells, the authors concluded that inflammatory cyto-
kine-induced T cell priming is essential for productive T
cell activation, regardless of the status of costimulatory
molecules. In the framework of the model proposed in
this paper, we suggest that the lack of responsiveness
in Myd88-deficient mice may be due to inefficient c-Rel/
IκBα complex formation in T cells in the absence of
inflammatory cytokines.
Most of our analyses were carried out under condi-
tions of low but continuous inflammatory-cytokine
treatment. However, initial experiments showed that the
shift of c-Rel to IκBα also occurred with a short, acute
pulse of TNF-α (Figure 1). Moreover, c-Rel/IκBα com-
plexes were present as long as 6 hr after removal of
TNF-α, at a time when IκBα and IκBβ levels had been
restored to starting levels. These observations indicate
that the “memory” of prior inflammatory cytokine acti-
vation, in the form of c-Rel/IκBα complexes, lasts quite
a long time. During this period the cells remain hyper-
responsive to TCR signals, and it is tempting to specu-
late that such primed cells may be targets for stimula-
tion by autoantigens. Such aberrant, CD28-independent,
T cell activation could result in a breakdown of self-
tolerance. Although we have only explored inflamma-
tory cytokines in this study, other IκB-degrading signals
are likely to have the same effect. To this end, we found
that low-level CD3 activation, which had no measurable
effect on cytokine gene transcription or NF-κB activa-
tion, also generated c-Rel/IκBα complexes and primed
cells for subsequent TCR-mediated activation (D.B.,
unpublished observation).
Lastly, we found that IL-2 and IFN-γ gene induction
in primary CD4+ T cell blasts was c-Rel independent.
Moreover, these cells could no longer be primed with
TNF-α plus IL-1β to increase cytokine gene transcrip-
tion. Thus, c-Rel-dependent cytokine gene expression
and the ability to be primed are features of naive T cells
only. These observations are consistent with the view
that c-Rel plays a crucial role as a danger sensor in T
cells. It is well established that naive cells are particu-
larly refractory for IL-2 or IFN-γ gene transcription (Gro-
gan et al., 2001; London et al., 2000; London et al.,
1999), presumably to minimize full-fledged T cell activa-
tion unless there is a real need. We suggest that the
dampened response is, in part, due to the requirement
for c-Rel for robust transcription of these genes, al-
though other NF-κB family members can partially com-
pensate for the absence of c-Rel. However, because
c-Rel is associated mainly with IκBβ in naive T cells, it
is not easily inducible. The difficulty of c-Rel induction
can be circumvented in (at least) two ways: by provision
of a costimulatory (CD28) signal that increases IκBβ
degradation and by pro-inflammatory cytokine signals
that shift c-Rel to IκBα-associated complexes. Both
means of increasing c-Rel responsiveness in T cells are
the result of innate immune cells’ “danger-sensing”
mechanisms that are mediated by Toll-like receptors.
Effector cells that arise as a result of the primary re-
sponse have already been tested for the “need” to re-
spond and therefore may not require additional signalsfor cytokine gene induction. This is reflected in a re-
duced requirement for c-Rel.
Experimental Procedures
Mice
All mice used for the experiment were 6–8 weeks old. C57BL6 (B6)
and DO11.TCR Tg/Rag−/− mice were purchased from Taconic
Farms (Germantown, NY), and c-Rel−/− mice were generously pro-
vided by the lab of Dr. Hsiou-Chi Liou (Cornell University Medical
College, NY). These mice were bred in the Brandeis University Ani-
mal Care Facility, and all in vivo studies were done in compliance
with the guidelines of our facility and the ACUC.
Cell Cultures and Reagents
D5h3 CD4+ T cell hybridoma cells were maintained in DMEM (Gibco
Invitrogen, Carlsbad, CA) medium supplemented with 10% FBS,
1% penicillin and streptomycin, 1 mM L-glutamine, and 50 M β-mer-
captoethanol. All antibodies were purchased from Santa Cruz Bio-
technology, CA, except anti-CD3 mAb (BD Pharmingen, San Diego,
CA). Murine TNF-α and IL-1β cytokines for in vitro treatment were
obtained from R and D Systems (Mineapolis, MN) and Roche Bio-
chemical (Indianapolis, IN), respectively, and cytokines for intraper-
itoneal injections were from Peprotech (Rocky Hill, NJ). Complete
and incomplete Freund’s (CFA/IFA) were purchased from Difco
Laboratories (Detroit, MI).
Intraperitoneal Injections and Cell Isolation
200 l of an emulsion of CFA/IFA in PBS was injected into each of
5–6 age-matched littermates per experiment, and this was followed
by another dose of IFA on the next day. For adjuvant cytokines,
250 ng of TNF-α and 500 ng of IL-1β was injected on three consec-
utive days. These cytokines were reconstituted in PBS without car-
rier bovine serum albumin. PBS alone was used as a negative con-
trol for all experiments. The animals were sacrificed on day 5, and
single-cell suspensions from spleen and lymph nodes (LNs) were
treated with CD4+ L3T4 microbeads and purified with MACS mag-
netic columns (Miltenyi Biotech, Auburn, CA.) as specified by the
manufacturer. This protocol yielded cells with >95% purity as as-
sessed by flow cytometry. Negative selection of total T cells was
carried out with the Pan-T isolation kit from Miltenyi Biotech.
Primary T Cell Activation
Freshly isolated CD4+ T cells were treated continuously with TNF-α
(5 ng/ml), IL-1β (5 ng/ml), or TNF-α and IL-1β for 6 hr or as indi-
cated. These cells were collected by centrifugation and plated at a
density of 1 × 106/ml in six-well plates precoated with 0.5 g/ml of
anti-CD3 mAb (BD Pharmingen). Cells were harvested at various
times for RNA and protein analyses. All activation assays were car-
ried out in duplicate for each time point.
Preparation of CD3 Blast Cells
Purified CD4+ T cells were activated with anti-CD3 (1 g/ml), anti-
CD28 (2 g/ml, soluble), and recombinant human (rh) IL-2 (10 ng/ml,
BD Pharmingen) for 2 days followed by a further 2 days of growth
rhIL-2 to generate blasts. These cells were washed, rested over-
night in media lacking rhIL-2, and activated with plate bound anti-
CD3 and soluble anti-CD28 at the concentrations as indicated.
RNA Isolation and Real-Time Reverse-Transcription PCR
RNA was isolated by with the RNeasy Mini kit (Qiagen, Valencia,
CA.) and 200–500 ng was used for reverse transcription (RT) with
Superscript III reverse transcriptase (Invitrogen). The RT reaction
was diluted 1:10 and 1–2 l was used for real-time RT-PCR with
SYBR-Green I detection via a Rotor-Gene 2000 (Corbett Research,
USA). Appropriate standards were generated for the IL-2 and IFN-γ
genes with RNA prepared from DC27.10 CD4+ T hyridoma cells and
primary CD8+ T cells, respectively, that were activated with immo-
bilized anti-CD3 (2 g/ml) and soluble anti-CD28 (2 g/ml) for 4 hr.
The Ct values of the samples were determined from the standard
curve by a method similar to that used by Ramos-Payan et al.
(Ramos-Payan, 2003). IL-2 and IFN-γ mRNA levels were normalized
to that of TCR Cβ2 to get the "absolute" mRNA. For "Fold Induction,"
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treated controls.
Primer sequences:
IL-2
FP: 5#-CCTGAGCAGGATGGAGAATTACA-3#
RP: 5#-TCCAGAACATGCCGCAGAG-3#
IFN-γ
FP: 5#-GCGTCATTGAATCACACCTG -3#
RP: 5#-GACCTCAAACTTGGCAATACTCATG-3#
C-beta
FP: 5#-GCCGAGCAGACTGTGGAATC-3#
RP: 5#-GGAATTTTTTTTCTTGACCATGGCC-3#
IκBα
FP: 5#-GACGGAGACTCGGTTCCTGC-3#
RP: 5#-GTGGAGTGGAGTCTGCTGC-3#
Extracts and Immunoprecipitations
Nuclear and whole-cell extracts (WCE) were prepared as described
(Tam et al., 2001, Xu et al., 2003). WCE (50–100 g) was treated
with anti-IκBα (sc-371, Santa Cruz) or anti-IκBβ (sc-945, Santa
Cruz) antibodies, and the immunoprecipitates were collected on
protein A agarose beads (Roche Pharmaceuticals). After fraction-
ation through 8% SDS-PAGE, proteins were transfered to nitrocel-
lulose membranes, which were probed with anti-c-Rel or anti-p65
antibodies. Detection was carried out with the West pico chemilu-
minescent kit (Pierce/Fisher). The supernatants were precipitated
with acetone and checked via immunoblotting to ensure complete
depletion of the respective proteins.
Electrophoretic Mobility-Shift Assay
Binding assays were performed with T cell nuclear extracts pre-
pared as above. Probes used for an electrophoretic mobility-shift
assay (EMSA) were the H2KκB element and the E3 binding site
from the immunoglobulin heavy-chain gene enhancer. All probes
and conditions for the EMSA have been previously described (Ven-
kataraman et al., 1995).
Gel Quantitation
The Quantity One Software program (Biorad) was used to quanti-
tate band intensities in Western blots. As per the software usage
protocol, tiny boxes were made around each band of interest, and
a same-sized box in close proximity determined the background.
This background number was automatically subtracted by the pro-
gram from the raw numbers assigned for each band to give the net
band intensities. The net band intensity of c-Rel associated with
IkBβ was then divided by that of c-Rel associated with IκBα. IκB-
associated p65 was treated similarily. The ratios from three inde-
pendent experiments were averaged to generate Figures 4D and
5D; the error bars represent the standard error between experi-
ments.
MSCV Retroviral Infection
The construct, dominant-negative IκB (DN-IκB) expressing GFP-
MSCV retroviral vector, was a generous gift from Dr. B. Horwitz
(Department of Pathology, Brigham and Women’s Hospital, MA).
The N terminal NES-mutated IκB-α (NES-IkB-α) fragment (Tam et
al., 2001) from a pc-DNA3 vector was cloned into MSCV-GFP vec-
tor into the ECoR1/BamH1 sites. These constructs were trans-
fected into packaging cell lines, BOSC 23 by the CaCl2/HBS
method of Van Parjis et al. (Van Parijs et al., 1999), to generate the
virus. Viral supernatants collected 48 hr and 72 hr after transfection
were used to spin-infect D5h3 hybridoma cells. After 48 hr, the
GFP+ and GFP− cells were sorted to 99% purity by FACS (Becton
Dickinson) for activation and RNA analyses.
SiRNA Nucleofection
Splenic CD4+ T cells were isolated by positive selection and
electroporated with an AMAXA nucleofector device according to
the manufacturer’s protocol with the following modifications. After
purification, cells were rested for approximately 1 hr at 37°C and
then transfected with 3.5 g of control or IκBα siRNA (Dharmacon,
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Ghicago, IL). Approximately 2 × 106 cells were used per electropo-
ation. Overall cell viability after electroporation was approximately
5%. The cells were allowed to recover for 3 hr before being
reated with IL-1β (ng/ml) for 6 hr, followed by anti-CD3 treatment
0.5 g/ml) for an additional 4 hr. Total RNA was used to quantitate
L-2 and IFN-γ gene expression by RT-PCR as described above.
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ight supplemental figures are available with this article online at
ttp://immunity.com/cgi/content/full/23/4/445/DC1/.
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